In response to ongoing advocacy from the AASM and lots of different medical organizations, the Drug Enforcement Administration (DEA), in live performance with the Division of Well being and Human Companies (HHS), has issued a 3rd extension of telemedicine flexibilities for the prescribing of managed medicines by way of Dec. 31, 2025.
This extension was granted to stop lapses in care and permit for the prescribing of managed medicines through telemedicine encounters, even when the prescribing practitioner has not performed an in-person medical analysis of the affected person. The telemedicine flexibilities on this extension proceed to authorize practitioners to prescribe schedule II-V managed medicines through audio-video telemedicine encounters, together with schedule III-V narcotic managed medicines accepted by the Meals and Drug Administration (FDA) for upkeep and withdrawal administration remedy of opioid use dysfunction through audio-only telemedicine encounters, supplied that such prescriptions in any other case adjust to the necessities outlined in DEA steering paperwork and laws, and relevant federal and state regulation.
Be taught extra about telemedicine and ship questions on telemedicine flexibilities to coding@aasm.org.
Share This Story, Select Your Platform!
Associated Posts
